Patents by Inventor Che Yang

Che Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250333496
    Abstract: The present invention relates to compounds (e.g. ISVDs, polypeptides, polypeptide derivatives) capable of binding to Interleukin-6 (IL-6) and their use in the treatment of inflammatory diseases such as, e.g. cardiovascular disease (CVD).
    Type: Application
    Filed: July 10, 2025
    Publication date: October 30, 2025
    Inventors: Thomas Egebjerg, Jais Rose Bjelke, Che Yang, Steffen Reedtz-Runge, Katharina Luise Maria Kopp, Emma Balantic-Nielsen, Philip Jonas Sassene
  • Patent number: 12404325
    Abstract: The present invention relates to compounds (e.g. ISVDs, polypeptides, polypeptide derivatives) capable of binding to Interleukin-6 (IL-6) and their use in the treatment of inflammatory diseases such as, e.g. cardiovascular disease (CVD).
    Type: Grant
    Filed: September 11, 2024
    Date of Patent: September 2, 2025
    Assignee: Novo Nordisk A/S
    Inventors: Thomas Egebjerg, Jais Rose Bjelke, Che Yang, Steffen Reedtz-Runge, Katharina Luise Maria Kopp, Emma Balantic-Nielsen, Philip Jonas Sassene
  • Publication number: 20250101094
    Abstract: The present invention relates to compounds (e.g. ISVDs, polypeptides, polypeptide derivatives) capable of binding to Interleukin-6 (IL-6) and their use in the treatment of inflammatory diseases such as, e.g. cardiovascular disease (CVD).
    Type: Application
    Filed: September 11, 2024
    Publication date: March 27, 2025
    Inventors: Thomas Egebjerg, Jais Rose Bjelke, Che Yang, Steffen Reedtz-Runge, Katharina Luise Maria Kopp, Emma Balantic-Nielsen, Philip Jonas Sassene
  • Publication number: 20220249649
    Abstract: Polypeptides useful in the preparation of vaccine compositions against RSV are provided. Also disclosed are methods of enhancing subdominant antibody responses in a subject.
    Type: Application
    Filed: July 1, 2020
    Publication date: August 11, 2022
    Inventors: Bruno Correia, Fabian Sesterhenn, Che Yang, Jaume Bonet